Connecticut Innovations is taking a new investment approach as it prepares to launch a $200 million fund to spur bioscience research and development in the state. The fund, originally pitched by Gov. Dannel P. Malloy and approved by lawmakers during the recent legislative session, will provide grants, equity investments, loans and loan guarantees to bioscience related initiatives over the next 10 years. In addition to investing in early stage companies, however, CI will provi
Medical device company advances novel cardiac surgical tool, initiates first-in-man trials Connecticut Innovations (CI), the state’s quasi-public authority responsible for technology-based economic development, today announced that it has made a follow-on investment of $1 million in EpiEP Inc. (EpiEP) through its Eli Whitney Fund. This investment is part of a $1.6 million round of funding, also involving LaunchCapital and individual investors. This is CI’s second investment i
$500 million to jump start the Advanced Manufacturing Partnership Press Release from the White House, advanced manufacturing companies, take note: Today, at Carnegie Mellon University, President Obama launched the Advanced Manufacturing Partnership (AMP), a national effort bringing together industry, universities, and the federal government to invest in the emerging technologies that will create high quality manufacturing jobs and enhance our global competitiveness. Investing
Company expands into medical implant manufacturing Rocky Hill, Conn., August 4, 2011 – Connecticut Innovations (CI), the state’s quasi-public authority responsible for technology investing and innovation development, today announced that it has provided $1.2 million in funding to Oxford Performance Materials LLC (OPM) of South Windsor, Conn., through its BioScience Facilities Fund. OPM will use the funding for the purchase of an EOSINT P 800 selective laser sintering machine
Connecticut’s premier life science award, the CURE Award for Excellence, was presented to Pfizer, Inc. at the April 27 annual meeting of CURE (Connecticut United for Research Excellence) in New Haven. The award went to Pfizer for its investment in “multiple approaches to treating Alzheimer’s Disease.” Pfizer has no fewer than seven Alzheimer’s clinical projects ongoing and several more programs in earlier stages of development at its Groton research site.
Download PDF of rel